MX358561B - Métodos para diagnosticar la enfermedad valvular crónica. - Google Patents

Métodos para diagnosticar la enfermedad valvular crónica.

Info

Publication number
MX358561B
MX358561B MX2014014791A MX2014014791A MX358561B MX 358561 B MX358561 B MX 358561B MX 2014014791 A MX2014014791 A MX 2014014791A MX 2014014791 A MX2014014791 A MX 2014014791A MX 358561 B MX358561 B MX 358561B
Authority
MX
Mexico
Prior art keywords
valvular disease
animal
chronic valvular
sample
metabolite
Prior art date
Application number
MX2014014791A
Other languages
English (en)
Spanish (es)
Other versions
MX2014014791A (es
Inventor
P Laflamme Dorothy
S Hannah Steven
Li Qinghong
Original Assignee
Nestec Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nestec Sa filed Critical Nestec Sa
Publication of MX2014014791A publication Critical patent/MX2014014791A/es
Publication of MX358561B publication Critical patent/MX358561B/es

Links

Classifications

    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6803General methods of protein analysis not limited to specific proteins or families of proteins
    • G01N33/6806Determination of free amino acids
    • G01N33/6812Assays for specific amino acids
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/575Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/5758Immunoassay; Biospecific binding assay; Materials therefor for cancer involving compounds serving as markers for tumours, cancers or neoplasias, e.g. cellular determinants, receptors, heat shock/stress proteins, A-protein, oligosaccharides or metabolites
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/483Physical analysis of biological material
    • G01N33/487Physical analysis of biological material of liquid biological material
    • G01N33/49Blood
    • G01N33/491Blood by separating the blood components
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/92Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving lipids, e.g. cholesterol, lipoproteins, or their receptors
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2570/00Omics, e.g. proteomics, glycomics or lipidomics; Methods of analysis focusing on the entire complement of classes of biological molecules or subsets thereof, i.e. focusing on proteomes, glycomes or lipidomes
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00Detection or diagnosis of diseases
    • G01N2800/32Cardiovascular disorders
    • G01N2800/326Arrhythmias, e.g. ventricular fibrillation, tachycardia, atrioventricular block, torsade de pointes
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10TTECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
    • Y10T436/00Chemistry: analytical and immunological testing
    • Y10T436/14Heterocyclic carbon compound [i.e., O, S, N, Se, Te, as only ring hetero atom]
    • Y10T436/142222Hetero-O [e.g., ascorbic acid, etc.]
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10TTECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
    • Y10T436/00Chemistry: analytical and immunological testing
    • Y10T436/14Heterocyclic carbon compound [i.e., O, S, N, Se, Te, as only ring hetero atom]
    • Y10T436/142222Hetero-O [e.g., ascorbic acid, etc.]
    • Y10T436/143333Saccharide [e.g., DNA, etc.]
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10TTECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
    • Y10T436/00Chemistry: analytical and immunological testing
    • Y10T436/16Phosphorus containing
    • Y10T436/163333Organic [e.g., chemical warfare agents, insecticides, etc.]
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10TTECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
    • Y10T436/00Chemistry: analytical and immunological testing
    • Y10T436/20Oxygen containing
    • Y10T436/200833Carbonyl, ether, aldehyde or ketone containing
    • Y10T436/201666Carboxylic acid

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Immunology (AREA)
  • Chemical & Material Sciences (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Physics & Mathematics (AREA)
  • Biochemistry (AREA)
  • Pathology (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Analytical Chemistry (AREA)
  • General Physics & Mathematics (AREA)
  • Microbiology (AREA)
  • Cell Biology (AREA)
  • Biotechnology (AREA)
  • Biophysics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Bioinformatics & Computational Biology (AREA)
  • Endocrinology (AREA)
  • Ecology (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Other Investigation Or Analysis Of Materials By Electrical Means (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Measuring And Recording Apparatus For Diagnosis (AREA)
MX2014014791A 2012-06-05 2013-06-04 Métodos para diagnosticar la enfermedad valvular crónica. MX358561B (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201261655704P 2012-06-05 2012-06-05
PCT/US2013/044008 WO2013184628A1 (en) 2012-06-05 2013-06-04 Methods for diagnosing chronic valvular disease

Publications (2)

Publication Number Publication Date
MX2014014791A MX2014014791A (es) 2015-02-24
MX358561B true MX358561B (es) 2018-08-24

Family

ID=48626663

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2014014791A MX358561B (es) 2012-06-05 2013-06-04 Métodos para diagnosticar la enfermedad valvular crónica.

Country Status (12)

Country Link
US (1) US20150153353A1 (https=)
EP (1) EP2856170B1 (https=)
JP (1) JP6174689B2 (https=)
CN (1) CN104364658B (https=)
AU (1) AU2013271879B2 (https=)
BR (1) BR112014030243B1 (https=)
CA (1) CA2875331C (https=)
ES (1) ES2687979T3 (https=)
IN (1) IN2014DN10127A (https=)
MX (1) MX358561B (https=)
RU (1) RU2667634C2 (https=)
WO (1) WO2013184628A1 (https=)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2017097852A2 (en) * 2015-12-07 2017-06-15 Zora Biosciences Oy Use of ceramides and lpls in diagnosing cvd

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20060257943A1 (en) * 2005-01-25 2006-11-16 Cis Biotech, Inc. Ischemic biomarkers and their use to predict adverse neurological events from surgery
CA2690541A1 (en) * 2007-07-17 2009-01-29 Metabolon, Inc. Biomarkers for pre-diabetes, cardiovascular diseases, and other metabolic-syndrome related disorders and methods using the same
KR20100099158A (ko) * 2007-11-09 2010-09-10 보드 오브 리전츠 더 유니버시티 오브 텍사스 시스템 심근세포 생존과 심장 회복을 제어하는 MIR-15 집단의 마이크로RNAs
JP2011519049A (ja) * 2008-04-29 2011-06-30 イミューンエクサイト インコーポレイテッド 免疫調節組成物およびその使用方法
DK2271933T3 (da) * 2008-05-07 2013-04-02 Univ Strathclyde System og fremgangsmåde til cellekarakterisering
EP2391652A4 (en) * 2009-01-29 2013-01-02 Abbott Lab IL-1 BINDING PROTEINS
TW201209171A (en) * 2010-07-23 2012-03-01 Harvard College Methods of detecting diseases or conditions using phagocytic cells

Also Published As

Publication number Publication date
WO2013184628A1 (en) 2013-12-12
JP6174689B2 (ja) 2017-08-02
RU2667634C2 (ru) 2018-09-21
JP2015524066A (ja) 2015-08-20
CN104364658A (zh) 2015-02-18
IN2014DN10127A (https=) 2015-08-21
AU2013271879A1 (en) 2014-12-18
RU2014153109A (ru) 2016-08-10
EP2856170B1 (en) 2018-07-25
US20150153353A1 (en) 2015-06-04
EP2856170A1 (en) 2015-04-08
ES2687979T3 (es) 2018-10-30
BR112014030243A2 (pt) 2017-06-27
BR112014030243B1 (pt) 2022-07-05
CA2875331C (en) 2022-11-29
CN104364658B (zh) 2017-06-30
AU2013271879B2 (en) 2019-03-28
MX2014014791A (es) 2015-02-24
CA2875331A1 (en) 2013-12-12

Similar Documents

Publication Publication Date Title
CL2021000630A1 (es) Métodos para producir un anticuerpo anti-c5 (divisional de la solicitud no. 201701585)
BR112014009093A2 (pt) método e sistema de imagem dupla para geração de uma imagem multidimensional de uma amostra
IL244627A0 (en) Image analysis technique for the purpose of disease diagnosis
BR112014018995A2 (pt) Sistemas para executar ensaio automatizado
MX367004B (es) Metodo, sistema y programa de computadora para comparar imagenes.
LT2970345T (lt) 18f-žymėti pozitronų emisijos tomografijos (pet) vizualizacijos agentai, nukreipti į prostatos atžvilgiu specifinius membranos antigenus (psma)
BR112017004614A2 (pt) terapias de combinação com anticorpos anti-cd38
EA201400875A1 (ru) Антитела к cd47 и способы их применения
CR20130359A (es) Anticuerpos del cea
EP2967508A4 (en) INTRAOSSALE NEEDLE AND KITS WITH IT
AR094403A1 (es) Terapia de combinación de anticuerpos anti-her3
BR112016007112A2 (pt) Anticorpos que se ligam a angiopoietina 2 (ang-2) humana, usos de um anticorpo que se liga a angiopoietina 2 (ang-2) humana e combinação
Yamada et al. Another avenue for anatomy of income comparisons: Evidence from hypothetical choice experiments
IL242122B (en) Imaging biomarkers for the diagnosis and prognosis of back pain and related conditions
MX375421B (es) Metodos y equipos para predecir el riesgo de tener una enfermedad o evento cardiovascular.
UY36223A (es) Dispositivos para ensayos, métodos para realizar ensayos, kits para ensayos y método para fabricar dispositivos para ensayos
MX383423B (es) Método in vitro para el diagnóstico del síndrqme del intestino irritable y la enfermedad inflamatoria intestinal.
EA201591742A1 (ru) Способ улучшения диагностики заболеваний с использованием измеряемых аналитов
EA201500080A1 (ru) Способ in vitro диагностирования и мониторинга рака
BR112016006556A2 (pt) arranjos detectáveis, sistemas para diagnóstico, e métodos para produzir e usar os mesmos
BR112016003129A2 (pt) método para detectar infecção por h.pylori
BR112014009223A2 (pt) método para o diagnóstico da doença de niemann-pick
EP2813998A8 (en) Image inspection data creating device, image inspection data creating program, and image inspection data creating method
BR112017027304A2 (pt) método para o diagnóstico de doença de farber
UY33364A (es) Método para reducir la variabilidad general del porcentaje de humedad de los productos de madera

Legal Events

Date Code Title Description
FG Grant or registration